Scotia Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26,859
| Closed | -$1.06M | – | 829 |
|
|
2022
Q4 | $1.06M | Sell |
26,859
-7,392
| -22% | -$291K | 0.01% | 442 |
|
|
2022
Q3 | $1.24M | Sell |
34,251
-3,223
| -9% | -$116K | 0.01% | 414 |
|
|
2022
Q2 | $1.14M | Buy |
37,474
+3,258
| +10% | +$99.1K | 0.01% | 451 |
|
|
2022
Q1 | $1.05M | Buy |
34,216
+520
| +2% | +$15.9K | 0.01% | 499 |
|
|
2021
Q4 | $1.05M | Sell |
33,696
-3,440
| -9% | -$108K | 0.01% | 509 |
|
|
2021
Q3 | $567K | Sell |
37,136
-2,881
| -7% | -$44K | ﹤0.01% | 602 |
|
|
2021
Q2 | $745K | Sell |
40,017
-1,120
| -3% | -$20.9K | 0.01% | 562 |
|
|
2021
Q1 | $736K | Buy |
41,137
+240
| +0.6% | +$4.29K | 0.01% | 537 |
|
|
2020
Q4 | $629K | Sell |
40,897
-837
| -2% | -$12.9K | 0.01% | 518 |
|
|
2020
Q3 | $462K | Buy |
41,734
+167
| +0.4% | +$1.85K | 0.01% | 511 |
|
|
2020
Q2 | $522K | Buy |
41,567
+21
| +0.1% | +$264 | 0.01% | 418 |
|
|
2020
Q1 | $471K | Sell |
41,546
-20,963
| -34% | -$238K | 0.01% | 441 |
|
|
2019
Q4 | $820K | Sell |
62,509
-3,799
| -6% | -$49.8K | 0.01% | 422 |
|
|
2019
Q3 | $597K | Sell |
66,308
-629
| -0.9% | -$5.66K | 0.01% | 481 |
|
|
2019
Q2 | $660K | Sell |
66,937
-145
| -0.2% | -$1.43K | 0.01% | 473 |
|
|
2019
Q1 | $682K | Buy |
67,082
+378
| +0.6% | +$3.84K | 0.01% | 445 |
|
|
2018
Q4 | $421K | Buy |
66,704
+9,618
| +17% | +$60.7K | 0.01% | 483 |
|
|
2018
Q3 | $754K | Sell |
57,086
-7,271
| -11% | -$96K | 0.01% | 458 |
|
|
2018
Q2 | $314K | Hold |
64,357
| – | – | ﹤0.01% | 572 |
|
|
2018
Q1 | $315K | Buy |
64,357
+1,439
| +2% | +$7.04K | ﹤0.01% | 595 |
|
|
2017
Q4 | $178K | Buy |
62,918
+8,547
| +16% | +$24.2K | ﹤0.01% | 655 |
|
|
2017
Q3 | $160K | Buy |
54,371
+18,742
| +53% | +$55.2K | ﹤0.01% | 644 |
|
|
2017
Q2 | $112K | Buy |
35,629
+9,426
| +36% | +$29.6K | ﹤0.01% | 633 |
|
|
2017
Q1 | $105K | Buy |
26,203
+5,385
| +26% | +$21.6K | ﹤0.01% | 648 |
|
|
2016
Q4 | $160K | Sell |
20,818
-2
| -0% | -$15 | ﹤0.01% | 619 |
|
|
2016
Q3 | $169K | Buy |
+20,820
| New | +$169K | ﹤0.01% | 596 |
|